RESISTANCE TO DOXORUBICIN IN TUMOR-CELLS INVITRO AND INVIVO AFTER PRETREATMENT WITH VERAPAMIL

Publication type:
Journal article
Metadata:
Autoren
  • FV DONENKO
  • T EFFERTH
  • J MATTERN
  • LV MOROZ
  • M VOLM
Autoren-URL
https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=fis-test-1&SrcAuth=WosAPI&KeyUT=WOS:A1991EZ27100009&DestLinkType=FullRecord&DestApp=WOS_CPL
DOI
10.1159/000238833
Externe Identifier
  • Clarivate Analytics Document Solution ID: EZ271
  • PubMed Identifier: 1672849
ISSN
0009-3157
Ausgabe der Veröffentlichung
1
Zeitschrift
CHEMOTHERAPY
Schlüsselwörter
  • RESISTANCE
  • TUMOR CELLS
  • DOXORUBICIN
  • VERAPAMIL
Paginierung
57 - 61
Datum der Veröffentlichung
1991
Status
Published
Titel
RESISTANCE TO DOXORUBICIN IN TUMOR-CELLS INVITRO AND INVIVO AFTER PRETREATMENT WITH VERAPAMIL
Sub types
  • Article
Ausgabe der Zeitschrift
37

Data source: Web of Science (Lite)

Other metadata sources:
Autoren
  • FV Donenko
  • T Efferth
  • J Mattern
  • LV Moroz
  • M Volm
DOI
10.1159/000238833
eISSN
1421-9794
ISSN
0009-3157
Ausgabe der Veröffentlichung
1
Zeitschrift
Chemotherapy
Sprache
en
Online publication date
2009
Paginierung
57 - 61
Datum der Veröffentlichung
1991
Status
Published
Herausgeber
S. Karger AG
Herausgeber URL
http://dx.doi.org/10.1159/000238833
Datum der Datenerfassung
2017
Titel
Resistance to Doxorubicin in Tumor Cells in vitro and in vivo after Pretreatment with Verapamil
Ausgabe der Zeitschrift
37

Data source: Crossref

Abstract
Sarcoma 180 (S180) cells pretreated with verapamil increase their resistance to doxorubicin in vitro. This result could be confirmed by in vivo experiments using P388 cells. The mechanism for this resistance is different from the P-glycoprotein-mediated mechanism characteristic for multidrug-resistant cells.
Addresses
  • Institute of Clinical Oncology, All-Union Cancer Research Center, Moscow, USSR.
Autoren
  • FV Donenko
  • T Efferth
  • T Efferth
  • J Mattern
  • LV Moroz
  • M Volm
DOI
10.1159/000238833
eISSN
1421-9794
Externe Identifier
  • PubMed Identifier: 1672849
Open access
false
ISSN
0009-3157
Ausgabe der Veröffentlichung
1
Zeitschrift
Chemotherapy
Schlüsselwörter
  • Tumor Cells, Cultured
  • Animals
  • Mice, Inbred C57BL
  • Mice, Inbred DBA
  • Mice
  • Leukemia P388
  • Sarcoma 180
  • Verapamil
  • Doxorubicin
  • Membrane Glycoproteins
  • Drug Resistance
  • Time Factors
  • Male
  • ATP Binding Cassette Transporter, Subfamily B, Member 1
Sprache
eng
Medium
Print
Paginierung
57 - 61
Datum der Veröffentlichung
1991
Status
Published
Datum der Datenerfassung
1991
Titel
Resistance to doxorubicin in tumor cells in vitro and in vivo after pretreatment with verapamil.
Sub types
  • Comparative Study
  • Journal Article
Ausgabe der Zeitschrift
37

Data source: Europe PubMed Central

Abstract
Sarcoma 180 (S180) cells pretreated with verapamil increase their resistance to doxorubicin in vitro. This result could be confirmed by in vivo experiments using P388 cells. The mechanism for this resistance is different from the P-glycoprotein-mediated mechanism characteristic for multidrug-resistant cells.
Autoren
  • FV Donenko
  • T Efferth
  • J Mattern
  • LV Moroz
  • M Volm
Autoren-URL
https://www.ncbi.nlm.nih.gov/pubmed/1672849
DOI
10.1159/000238833
ISSN
0009-3157
Ausgabe der Veröffentlichung
1
Zeitschrift
Chemotherapy
Schlüsselwörter
  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Animals
  • Doxorubicin
  • Drug Resistance
  • Leukemia P388
  • Male
  • Membrane Glycoproteins
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred DBA
  • Sarcoma 180
  • Time Factors
  • Tumor Cells, Cultured
  • Verapamil
Sprache
eng
Country
Switzerland
Paginierung
57 - 61
Datum der Veröffentlichung
1991
Status
Published
Datum, an dem der Datensatz öffentlich gemacht wurde
1991
Titel
Resistance to doxorubicin in tumor cells in vitro and in vivo after pretreatment with verapamil.
Sub types
  • Comparative Study
  • Journal Article
Ausgabe der Zeitschrift
37

Data source: PubMed

Beziehungen:
Property of

Tools